Product Director - Synthetic Modality Drug Discovery

Astra Zeneca has invested heavily in our strategic synthetic drug modality IT platform as we deliver better, differentiated candidate drugs into trials, faster, expediting the benefit for patients. We have made great strides in creating an ecosystem enabling operational and experimental data capture, and in developing analytics, AI, and ML services for both traditional small molecules and complex modalities that will pave the way for this transformation. The next stage of this journey involves evolving and building out unified scientific ...